Imported from EML workbook.
Formulations: - Oral > Solid: 300 mg (as sulfate) + 100 mg tablet (heat stable) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
Formulations: - Oral > Solid: 75 mg; 400 mg; 600 mg; 800 mg Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
Formulations: - Oral > Solid > tablet: 100 mg + 25 mg tablet (heat-stable); 200 mg + 50 mg tablet (heat-stable) Oral > Solid > dosage form: 40 mg + 10 mg Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
Formulations: - Oral > Solid: 25 mg tablet (heat stable); 100 mg tablet (heat stable) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.
